MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1

European Journal of Neuroscience

Volumn 27, Issue 7, 2008, Pages 1634-1646

  Lo, Chen Peng ^a   Hsu, Li Jin ^a,b   Li, Meng Yen ^a   Hsu, Se Yei ^a   Chuang, Jih Ing ^a   Tsai, Ming Shu ^c   Lin, Sing Ru ^a   Chang, Nan Shan ^a,b,d   Chen, Shur Tzu ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c Potz General Hospital   (Taiwan)

^d GUTHRIE RESEARCH INSTITUTE   (United States)

Author keywords

Bcl 2; JNK1; MPP+; Neurodegeneration; p53; WOX1; WWOX

Indexed keywords

1 METHYL 4 PHENYL PYRIDINIUM; BRAIN EXTRACT; NEUROTOXIN; PROTEIN P53; PROTEIN WOX1; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR SUPPRESSOR PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NERVE DEGENERATION; NEUROBLASTOMA CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; HUMANS; MALE; NEURONS; OXIDOREDUCTASES; PARKINSON DISEASE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

EID: 41549121943     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06139.x     Document Type: Article

References (58)

1. Agid, Y. (1991) Parkinson's disease: pathophysiology. Lancet, 337, 1321 1324.
2. Aqeilan, R.I., Kuroki, T., Pekarsky, Y., Albagha, O., Trapasso, F., Baffa, R., Huebner, K., Edmonds, P. Croce, C.M. (2004) Loss of WWOX expression in gastric carcinoma. Clin. Cancer Res., 10, 3053 3058.
3. Aqeilan, R.I., Trapasso, F., Hussain, S., Costinean, S., Marshall, D., Pekarsky, Y., Hagan, J.P., Zanesi, N., Kaou, M., Stein, G.S., Lian, J.B. Croce, C.M. (2007) Targeted deletion of Wwox reveals a tumor suppressor function. Proc. Natl Acad. Sci. USA, 104, 3949 3954.
4. Bode, A.M. Dong, Z. (2007) The functional contrariety of JNK. Mol. Carcinog., 46, 591 598.
5. Borsello, T. Forloni, G. (2007) JNK signalling: a possible target to prevent neurodegeneration. Curr. Pharm. Des., 13, 1875 1886.
6. Chang, N.S., Doherty, J. Ensign, A. (2003a) JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J. Biol. Chem., 278, 9195 9202.
7. Chang, N.S., Doherty, J., Ensign, A., Lewis, J., Heath, J., Schultz, L., Chen. S.T. Oppermann, U. (2003b) Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses. Biochem. Pharmacol., 66, 1347 1354.
8. Chang, N.S., Doherty, J., Ensign, A., Schultz, L., Hsu, L.J. Hong, Q. (2005a) WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53. J. Biol. Chem., 280, 43100 43108.
9. Chang, N.-S., Hsu, L.J., Lin, Y.S., Lai, F.J. Sheu, H.M. (2007) WW domain-containing oxidoreductase: a candidate tumor suppressor. Trends Mol. Med., 13, 12 22.
10. Chang, N.S., Pratt, N., Heath, J., Schultz, L., Sleve, D., Carey, G.B. Zevotek, N. (2001) Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J. Biol. Chem., 276, 3361 3370.
11. Chang, N.S., Schultz, L., Hsu, L.J., Lewis, J., Su, M. Sze, C.I. (2005b) 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Oncogene, 24, 714 723.
12. Chen, S.T., Chuang, J.I., Cheng, C.L., Hsu, L.J. Chang, N.S. (2005) Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo. Neuroscience, 130, 397 407.
13. +-induced neurodegeneration glutathione impairment in the nigrostriatal dopaminergic pathway. J. Pineal Res., 32, 262 269.
14. Chen, S.T., Chuang, J.I., Wang, J.P., Tsai, M.S., Li, H. Chang, N.S. (2004) Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system. Neuroscience, 124, 831 839.
15. + in the rat. Neurochem. Int., 40, 169 179.
16. Chuang, J.I., Chen, S.T., Chang, Y.H. Jen, L.S. (2001) Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment. J. Chem. Neuroanat., 21, 215 223.
17. 2-terminal kinase in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurofilament phosphorylation. J. Neurosci. Res., 83, 680 693.
18. Degen, W.G., Pruijn, G.J., Raats, J.M. van Venrooij, W.J. (2000) Caspase-dependent cleavage of nucleic acids. Cell Death Differ., 7, 616 627. Review.
19. Driouch, K., Prydz, H., Monese, R., Johansen, H., Lidereau, R. Frengen, E. (2002) Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene, 21, 1832 1840.
20. Eberhardt, O. Schulz, J.B. (2003) Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease. Toxicol. Lett., 139, 135 151.
21. Gallo, K.A. Johnson, G.L. (2002) Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol., 3, 663 672.
22. Glotin, A.L., Calipel, A., Brossas, J.Y., Faussat, A.M., Treton, J. Mascarelli, F. (2006) Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells. Invest. Ophthalmol. Vis. Sci., 47, 4614 4623.
23. Hartley, A., Stone, J.M., Heron, C., Cooper, J.M. Schapira, A.H.V. (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem., 63, 1987 1990.
24. Hartmann, A., Troadec, J.D., Hunot, S., Kikly, K., Faucheux, B.A., Mouatt-Prigent, A., Ruberg, M., Agid, Y. Hirsch, E.C. (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal death. J. Neurosci., 21, 2247 2255.
25. Heikkila, R.E., Hess, A. Duvoisin, R.C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science, 224, 1451 1453.
26. Heikkila, R.E., Nicklas, W.J., Vyas, I. Duvoisin, R.C. (1985) Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci. Lett., 62, 389 394.
27. Hong, Q., Hsu, L.J., Schultz, L., Pratt, N., Mattison, J. Chang, N.S. (2007) Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response. BMC Mol. Biol., 8, 50.
28. Hsu, L.J., Schultz, L., Mattison, J., Lin, Y.S. Chang, N.S. (2005) Cloning and characterization of a small size peptide Zfra that regulates the cytotoxic function of tumor necrosis factor by interacting with JNK1. Biochem. Biophys. Res. Commun., 327, 415 423.
29. Klein, J.A., Longo-Guess, C.M., Rossmann, M.P., Seburn, K.L., Hurd, R.E., Frankel, W.N., Bronson, R.T. Ackerman, S.L. (2002) The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature, 419, 367 374.
30. Lai, F.J., Cheng, C.L., Chen, S.T., Wu, C.H., Hsu, L.J., Lee, J.Y., Chao, S.C., Sheen, M.C., Shen, C.L., Chang, N.-S. Sheu, H.M. (2005) WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo. Clin. Cancer Res., 11, 5769 5777.
31. Langston, J.W. (1996) The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology, 47, S153 S160.
32. Lipton, S.A. Bossy-Wetzel, E. (2002) Dueling activities of AIF in cell death versus survival. DNA binding and redox activity. Cell, 111, 147 150.
33. Liu, Y. Edwards, R.H. (1997) The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu. Rev. Neurosci., 20, 125 156.
34. Ludes-Meyers, J.H., Kil, H., Nunez, M.I., Conti, C.J., Parker-Thornburg, J., Bedford, M.T. Aldaz, C.M. (2007) WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer, 46, 1129 1136.
35. Mahajan, N.P., Whang, Y.E., Mohler, J.L. Earp, H.S. (2005) Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res., 65, 10514 10523.
36. Nicotra, A. Parvez, S.H. (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol. Teratol., 24, 599 605.
37. Offen, D., Beart, P.M., Cheung, N.S., Pascoe, C.J., Hochman, A., Gorodin, S., Melamed, E., Bernard, R. Bernard, O. (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc. Natl Acad. Sci. USA, 95, 5789 5794.
38. Paige, A.J.W., Taylor, K.J., Taylor, C., Hillier, S.G., Farrington, S., Scott, D., Porteous, D.J., Smyth, J.F., Gabra, H. Watson, J.E. (2001) WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc. Natl Acad. Sci. USA, 98, 11417 11422.
39. Peng, J. Anderson, J.K. (2003) The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease. IUBMB Life, 55, 267 271.
40. Saporito, M.S., Brown, E.M., Miller, M.S. Carswell, S. (1999) CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J. Pharmacol. Exp. Ther., 288, 421 427.
41. Sbrana, I., Veroni, F., Nieri, M., Puliti, A. Barale, R. (2006) Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer. Gene Chromosome Cancer, 45, 429 436.
42. Schapira, A.H., Gu, M., Taanman, J.W., Tabrizi, S.J., Seaton, T., Cleeter, M. Cooper, J.M. (1998) Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann. Neurol., 44, S89 S98.
43. Schober, A. (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res., 318, 215 224.
44. Smith, D.I., McAvoy, S., Zhu, Y. Perez, D.S. (2007) Large common fragile site genes and cancer. Semin. Cancer Biol., 17, 31 41.
45. Speciale, S.G. (2002) MPTP: insights into parkinsonian neurodegeneration. Neurotoxicol. Teratol., 24, 607 620.
46. Swerdlow, R.H., Parks, J.K., Miller, S.W., Tuttle, J.B., Trimmer, P.A., Sheehan, J.P., Bennett, J.P. Jr., Davis, R.E. Parker, W.D. Jr. (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol., 40, 663 671.
47. Sze, C.I., Su, M., Pugazhenthi, S., Jambal, P., Hsu, L.J., Heath, J., Schultz, L. Chang, N.S. (2004) Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease. J. Biol. Chem., 279, 30498 30506.
48. Tatton, N.A. Kish, S.J. (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labeling and acridine orange staining. Neuroscience, 77, 1037 1048.
49. Tieu, K., Ischiropoulos, H. Przedborski, S. (2003) Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life, 55, 329 335.
50. Tournier, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N., Flavell, R.A. Davis, R.J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science, 288, 870 874.
51. Trimmer, P.A., Smith, T.S., Jung, A.B. Bennett, J.P. Jr. (1996) Dopamine neurons from transgenic mice with knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration, 5, 233 239.
52. Vila, M. Przedborski, S. (2003) Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci., 4, 365 375.
53. Viswanath, V., Wu, Y., Boonplueang, R., Chen, S., Stevenson, F.F., Yantiri, F., Yang, L., Beal, M.F. Andersen, J.K. (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci., 21, 9519 9528.
54. Watanabe, A., Hippo, Y., Taniguchi, H., Iwanari, H., Yashiro, M., Hirakawa, K., Kodama, T. Aburatani, H. (2003) An opposing view on WWOX protein function as a tumor suppressor. Cancer Res., 63, 8629 8633.
55. Xia, X.G., Harding, T., Weller, M., Bieneman, A., Uney, J.B. Schulz, J.B. (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA, 98, 10433 10438.
56. Yamada, T., Goto, M., Punj, V., Zaborina, O., Chen, M.L., Kimbara, K., Majumdar, D., Cunningham, E., Das Gupta, T.K. Chakrabarty, A.M. (2002) Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc. Natl Acad. Sci. USA, 99, 14098 14103.
57. Yang, L., Matthew, R.T., Schulz, J.B., Klockgether, T., Liao, A.W., Martinou, J.C., Penney, J.B. Jr., Hyman, B.T. Beal, M.F. (1998) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci., 18, 8145 8152.
58. Yendamuri, S., Kuroki, T., Trapasso, F., Henry, A.C., Dumon, K.R., Huebner, K., Williams, N.N., Kaiser, L.R. Croce, C.M. (2003) WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res., 63, 878 881.